Filing Details
- Accession Number:
- 0001209191-19-010383
- Form Type:
- 5
- Zero Holdings:
- No
- Publication Time:
- 2019-02-14 18:07:00
- Reporting Period:
- 2018-12-31
- Accepted Time:
- 2019-02-14 18:07:00
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1180262 | Herbalife Nutrition Ltd. | HLF | Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1472187 | Edi Hienrich | 800 W. Olympic Blvd. Suite 406 Los Angeles CA 90015 | Svp/Managing Director Emea | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2018-03-02 | 4,404 | $30.44 | 2,780 | No | 4 | M | Indirect | By wife |
Common Stock | Disposition | 2018-03-02 | 2,919 | $94.72 | 2,780 | No | 4 | F | Indirect | By wife |
Common Stock | Disposition | 2018-03-02 | 104 | $91.77 | 2,780 | No | 4 | S | Indirect | By wife |
Common Stock | Disposition | 2018-03-02 | 183 | $93.00 | 2,780 | No | 4 | S | Indirect | By wife |
Common Stock | Disposition | 2018-03-06 | 1,485 | $95.57 | 2,780 | No | 4 | S | Indirect | By wife |
Common Stock | Acquisiton | 2018-05-09 | 655 | $62.51 | 2,780 | No | 4 | M | Indirect | By wife |
Common Stock | Disposition | 2018-05-09 | 526 | $111.17 | 2,780 | No | 4 | F | Indirect | By wife |
Common Stock | Disposition | 2018-05-11 | 129 | $111.46 | 2,780 | No | 4 | S | Indirect | By wife |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Indirect | By wife |
No | 4 | F | Indirect | By wife |
No | 4 | S | Indirect | By wife |
No | 4 | S | Indirect | By wife |
No | 4 | S | Indirect | By wife |
No | 4 | M | Indirect | By wife |
No | 4 | F | Indirect | By wife |
No | 4 | S | Indirect | By wife |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Appreciation Rights | Disposition | 2018-03-02 | 4,404 | $0.00 | 4,404 | $30.44 |
Common Stock | Stock Appreciation Rights | Disposition | 2018-05-09 | 655 | $0.00 | 655 | $62.51 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2018-03-02 | 2025-03-02 | No | 4 | M | Indirect |
3,930 | 2026-05-09 | No | 4 | M | Indirect |
Footnotes
- This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person's wife.
- The Reporting Person's wife received 1,485 shares of common stock upon the net exercise of 4,404 stock appreciation rights ("SARS"). The Reporting Person's wife forfeited 1,416 shares of common stock underlying the SARS in payment of the exercise price and 1,503 shares of common stock underlying the SARS to satisfy the withholding tax obligations resulting from the exercise, using the closing stock price on March 2, 2018 of $94.72. Since this transaction took place prior to the Issuer's 2-for-1 stock split on May 14, 2018, share numbers, market prices and exercise prices are provided without giving effect to the stock split.
- Balance reflects the amount of securities beneficially owned indirectly as of December 31, 2018, after giving effect to the Issuer's 2-for-1 stock split on May 14, 2018.
- Since this transaction took place prior to the Issuer's 2-for-1 stock split on May 14, 2018, share numbers and market price are provided without giving effect to the stock split.
- The Reporting Person's wife received 129 shares of common stock upon the net exercise of 655 SARS. The Reporting Person's wife forfeited 369 shares of common stock underlying the SARS in payment of the exercise price and 157 shares of common stock underlying the SARS to satisfy the withholding tax obligations resulting from the exercise, using the closing stock price on May 9, 2018 of $111.17. Since this transaction took place prior to the Issuer's 2-for-1 stock split on May 14, 2018, share numbers, market prices and exercise prices are provided without giving effect to the stock split.
- On May 9, 2016, the Reporting Person's wife was granted 3,275 SARS (prior to giving effect to the Issuer's 2-for-1 stock split on May 14, 2018). These SARS vested 20% each on May 9, 2017 and May 9, 2018, and the remaining 60% vests on May 9, 2019.
- Reflects share numbers after giving effect to the Issuer's 2-for-1 stock split on May 14, 2018.